Clinical trial
Secondary Prevention of Osteoporosis
NCT00421343 · Hebrew SeniorLife, Other · Completed
Key facts
| NCT number | NCT00421343 |
|---|---|
| Title | Secondary Prevention of Osteoporosis |
| Official title | Secondary Prevention of Osteoporosis: A Window of Opportunity in the Acute Rehabilitation Setting |
| Lead sponsor | Hebrew SeniorLife, Other |
| Collaborators | National Institute on Aging (NIA) NIH Merck Sharp & Dohme LLC Industry GlaxoSmithKline |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Behavioral, Drug |
| Interventions | alendronate with cholecalciferol, calcium carbonate with cholecalciferol, Falls prevention measures |
| Enrollment | 29 |
| Start date | Feb 1, 2007 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Jan 12, 2007 |
| Last update posted | Feb 5, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: